<DOC>
	<DOCNO>NCT00512538</DOCNO>
	<brief_summary>The purpose study determine ability Apligraf improve time incidence complete wound closure diabetic foot ulcer , compare diabetic foot ulcer treat standard therapy .</brief_summary>
	<brief_title>Apligraf Versus Standard Therapy Treatment Diabetic Foot Ulcers</brief_title>
	<detailed_description>Ulceration diabetic foot result multiple problem include repetitive stress neuropathic insensate area often associate underlying bony prominence . By heal diabetic foot ulcer quickly risk infection , osteomyelitis ( infeciton bone ) limb loss reduce . This study evaluate ability Apligraf heal diabetic foot ulcer present least 2 week 1 - 16 cm2 area . Patients randomize either ( 50:50 chance ) treatment Apligraf saline moisten dress regimen ( standard therapy ) . All patient receive standard care ulcer include debridement , orthotics off-loading throughout treatment period .</detailed_description>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>diabetic ulcer primarily neuropathic origin plantar region forefoot ulcer extend dermis without sinus tract , tendon , capsule bone exposure ulcer present least 2 week measure 1 16 cm2 diminish sensesation target extremity/foot ulcer infect Type 1 2 diabetes adequate glycemic control Adequate vascular supply target extremity Charcot foot Nonneuropathic ulcer Skin cancer within adjacent target ulcer Osteomyelitis infect ulcer Clinically significant medical condition would impair wound heal Females pregnant Received within 4 week study entry systemic corticosteriods , immunosuppresive agent , radiation therapy chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Diabetic foot</keyword>
</DOC>